L-ELISA of human GDF15 quantifies human GDF15 in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human GDF15. Principle of the L-ELISA method...
L-ELISA of human GDF15 quantifies human GDF15 in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human GDF15. L-ELISA solid phase sandwich principle of human GDF15 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Bone morphogenetic proteins (e.g., BMP5; MIM 112265) are members of the beta transformant growth factor superfamily (see TGF-beta1; MIM 190180) and regulate tissue differentiation and maintenance. They are synthesized as precursor molecules that are treated at a dibasic cleavage site to release C-terminal end domains containing a characteristic pattern of the 7 cysteins retained in the mature protein.
Sensitivity
Sensitivity of the dosage: 0.59 pg/ml.
Measurement range
Dose range: 2-125 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of variation between doses 4.2%, interdose 2.9%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 16362004 |
| Specifications |
| Accession number | Q99988 |
| Dose range | 2-125 pg/ml |
| Sensitivity of the dosage | 0.59 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 9518 |
| Gene symbol(s) | GDF15 |
| Coefficient of inter-dose variation | 2.9% |
| Coefficient of intra-dose variation | 4.2% |
| Contents of kits | Pre-coated well plate 96, Standard, sample diluent, dosing buffer concentrate, biotinylated detection antibodies, SAV-HRP, washing pad, chromogen, stop solution, adhesive film for plates |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 10 μl; serum, 10 μl; supernatant, 10 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2258 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.